Trends in the exploitation of novel drug targets

Rask-Andersen, Mathias, Almén, Markus Sällman, Schiöth, Helgi B.·2011·Nature Reviews Drug Discovery

Cited by (872)

Items 101–200 of 872

  1. Drug Repositioning Through Network Pharmacology
    Hao Ye, Wei Ping Jia, Kailin Tang, Ritchie J. Feuers, Huixiao Hong · 2016 · Current Topics in Medicinal Chemistry
  2. Orphan G protein-coupled receptors: The role in CNS disorders
    Mohaddeseh Sadat Alavi, Ali Shamsizadeh, Hassan Azhdari‐Zarmehri, Ali Roohbakhsh · 2017 · Biomedicine & Pharmacotherapy
  3. The G protein-coupled receptors deorphanization landscape
    Céline Laschet, Nadine Dupuis, Julien Hanson · 2018 · Biochemical Pharmacology
  4. S1PR1 is an effective target to block STAT3 signaling in activated B cell–like diffuse large B-cell lymphoma
    Yong Liu, Jiehui Deng, Lin Wang, Heehyoung Lee, Brian Armstrong, Anna Scuto, Claudia M. Kowolik, Lawrence Martin Weiss, Stephen J. Forman, Hua Yu · 2012 · Blood
  5. Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features
    Dongsheng Cao, Liu‐Xia Zhang, Gui‐Shan Tan, Zheng Xiang, Wen‐Bin Zeng, Qing‐Song Xu, Alex F. Chen · 2014 · Molecular Informatics
  6. Clinical Success of Drug Targets Prospectively Predicted by In Silico Study
    Feng Zhu, Xiao Xu Li, Sheng Yong Yang, Yu Chen · 2017 · Trends in Pharmacological Sciences
  7. Emerging targetome and signalome landscape of gut microbial metabolites
    Xiao Zheng, Xiaoying Cai, Haiping Hao · 2022 · Cell Metabolism
  8. The impact of in silico screening in the discovery of novel and safer drug candidates
    Didier Rognan · 2017 · Pharmacology & Therapeutics
  9. Insights into drug discovery from natural medicines using reverse pharmacokinetics
    Haiping Hao, Xiao Zheng, Guangji Wang · 2014 · Trends in Pharmacological Sciences
  10. Structure-Based Ligand Discovery Targeting Orthosteric and Allosteric Pockets of Dopamine Receptors
    J. Robert Lane, Pavel Chubukov, Wei Liu, Meritxell Canals, Vadim Cherezov, Ruben A Abagyan, Raymond C. Stevens, Vsevolod Katritch · 2013 · Molecular Pharmacology
  11. Solute carriers as drug targets: Current use, clinical trials and prospective
    Mathias Rask‐Andersen, Surendar Masuram, Robert Fredriksson, Helgi B. Schiöth · 2013 · Molecular Aspects of Medicine
  12. Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
    Ruili Yin, Yongsong Xu, Xin Wang, Longyan Yang, Dong Zhao · 2022 · Molecules
  13. G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease
    Nina Divorty, Amanda E. Mackenzie, Stuart A. Nicklin, Graeme Milligan · 2015 · Frontiers in Pharmacology
  14. Tinnitus: network pathophysiology-network pharmacology
    Ana Belén Elgoyhen, Berthold Langguth, Sven Vanneste, Dirk De Ridder · 2012 · Frontiers in Systems Neuroscience
  15. Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer
    Francisco Alejandro Lagunas‐Rangel, Jenni Viivi Linnea‐Niemi, Błażej Kudłak, Michael J. Williams, Jörgen Jönsson, Helgi B. Schiöth · 2022 · GeoHealth
  16. The Dispanins: A Novel Gene Family of Ancient Origin That Contains 14 Human Members
    Markus Sällman Almén, Nathalie Bringeland, Robert Fredriksson, Helgi Birgir Schiöth · 2012 · PLoS ONE
  17. Sodium Ion Binding Pocket Mutations and Adenosine A2A Receptor Function
    Arnault Massink, Hugo Gutiérrez‐de‐Terán, Eelke Bart Lenselink, Natalia V. Ortiz Zacarı́as, Lizi Xia, Laura H. Heitman, Vsevolod Katritch, Raymond C. Stevens, Adriaan P. IJzerman · 2014 · Molecular Pharmacology
  18. Dynamic undocking and the quasi-bound state as tools for drug discovery
    Sergio Ruiz Carmona, Peter Schmidtke, Francisco Javier Luque, Lisa M. Baker, Natalia Matassova, Ben J. Davis, Stephen D. Roughley, James B. Murray, Rod E. Hubbard, Xavier Barril · 2016 · Nature Chemistry
  19. GPR151 in nociceptors modulates neuropathic pain via regulating P2X3 function and microglial activation
    Liping Xia, Hao Luo, Qiang Ma, Ya‐Kai Xie, Wei Li, Hailan Hu, Zhen‐Zhong Xu · 2021 · Brain
  20. Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily
    Roth, Bryan L., Kroeze, Wesley K. · 2015 · Journal of Biological Chemistry
  21. Gpr176 is a Gz-linked orphan G-protein-coupled receptor that sets the pace of circadian behaviour
    Masao Doi, Iori Murai, Sumihiro Kunisue, Genzui Setsu, Naohiro Uchio, Rina Tanaka, Sakurako Kobayashi, Hiroyuki Shimatani, Hida Hayashi, Hsu‐Wen Chao et al. · 2016 · Nature Communications
  22. Bioinformatics and variability in drug response: a protein structural perspective
    Jennifer L. Lahti, Grace W. Tang, Emidio Capriotti, Tianyun Liu, Russ Biagio Altman · 2012 · Journal of The Royal Society Interface
  23. Opportunities and Challenges in Developing Stearoyl-Coenzyme A Desaturase-1 Inhibitors as Novel Therapeutics for Human Disease
    Zaihui Zhang, Natalie A. Dales, Michael D. Winther · 2013 · Journal of Medicinal Chemistry
  24. Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology
    Jeonghun Han, Yukyung Jun, Kim Ys, Hong-Hoa Hoang, Yeonjoo Jung, Suyeon Kim, Jaesang Kim, Robert H. Austin, Sanghyuk Lee, Sungsu Park · 2016 · Proceedings of the National Academy of Sciences
  25. Optical Control of Dopamine Receptors Using a Photoswitchable Tethered Inverse Agonist
    Prashant Donthamsetti, Nils Winter, Matthias Schönberger, Joshua Levitz, Cherise Stanley, Jonathan A. Javitch, Ehud Y. Isacoff, Dirk H. Trauner · 2017 · Journal of the American Chemical Society
  26. Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development – A review
    Bin Deng, Cristina Lento, Derek J. Wilson · 2016 · Analytica Chimica Acta
  27. Use of artificial intelligence to enhance phenotypic drug discovery
    Sophia Malandraki-Miller, Paul Richard Riley · 2021 · Drug Discovery Today
  28. GPCRs: The most promiscuous druggable receptor of the mankind
    Khaled A. Alhosaini, Asim Azhar, Asma S. Alonazi, Fahad Al-Zoghaibi · 2021 · Saudi Pharmaceutical Journal
  29. Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)
    Aishwarya L. Saraswat, Richa Vartak, Rehab R. Hegazy, Akanksha Patel, Ketan R. Patel · 2022 · Drug Discovery Today
  30. Quantum effects in the brain: A review
    Adams, Betony, Petruccione, Francesco · 2020 · AVS Quantum Science
  31. Understanding Membrane Protein Drug Targets in Computational Perspective
    Jianting Gong, Yongbing Chen, Feng Pu, Pingping Sun, Fei He, Li Zhang, Yanwen Li, Zhiqiang Ma, Han Wang · 2018 · Current Drug Targets
  32. A comparative analysis of human and mouse islet G-protein coupled receptor expression
    Stefan Amisten, Patricio Atanes, Ross G. Hawkes, Inmaculada Ruz‐Maldonado, Bo Liu, Fariborz Parandeh, Min Zhao, Guo Cai Huang, Albert A. Salehi, Shanta Jean Persaud · 2017 · Scientific Reports
  33. Protein–Ligand Blind Docking Using CB-Dock2
    Yang Liu, Yang Cao · 2023 · Methods in molecular biology
  34. Extracellular cues influencing oligodendrocyte differentiation and (re)myelination
    Natalie A. Wheeler, Babette Fuss · 2016 · Experimental Neurology
  35. Recent Applications of Diazirines in Chemical Proteomics
    Matthew W. Halloran, Jean‐Philip Lumb · 2018 · Chemistry - A European Journal
  36. Label-free drug discovery
    Fang Ye · 2014 · Frontiers in Pharmacology
  37. Toward G protein-coupled receptor structure-based drug design using X-ray lasers
    Andrii Ishchenko, Benjamin Stauch, Gye Won Han, A. Batyuk, Anna Shiriaeva, Chufeng Li, Nadia A. Zatsepin, Uwe Weierstall, Wei Liu, Eriko Nango et al. · 2019 · IUCrJ
  38. Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer’s disease
    Tsuji, Shingo, Hase, Takeshi, Yachie-Kinoshita, Ayako, Nishino, Taiko, Ghosh, Samik, Kikuchi, Masataka, Shimokawa, Kazuro, Aburatani, Hiroyuki, Kitano, Hiroaki, Tanaka, Hiroshi · 2021 · Alzheimer's Research & Therapy
  39. Heterotrimeric Gq proteins as therapeutic targets?
    Evi Kostenis, Eva Marie Pfeil, Suvi Annala · 2020 · Journal of Biological Chemistry
  40. Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
    Andrey D. Bondarev, Misty M. Attwood, Jörgen Jonsson, Vladimir N. Chubarev, Vadim V. Tarasov, Wen Liu, Helgi B. Schiöth · 2022 · Frontiers in Pharmacology
  41. Antibody informatics for drug discovery
    Hiroki Shirai, Catherine Prades, Randi Vita, Paolo Marcatili, Bojana Popovic, Jianqing Xu, John P. Overington, Kazunori Hirayama, Shinji Soga, Kazuhisa Tsunoyama et al. · 2014 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  42. RNA as a small molecule druggable target
    Noreen F. Rizvi, Graham F. Smith · 2017 · Bioorganic & Medicinal Chemistry Letters
  43. Time-resolved fluorescence ligand binding for G protein–coupled receptors
    Alexander Emami-Nemini, Thomas Roux, Marion Leblay, Emmanuel Bourrier, Laurent Lamarque, Eric Trinquet, Martin J. Lohse · 2013 · Nature Protocols
  44. A monoclonal antibody against KCNK9 K+ channel extracellular domain inhibits tumour growth and metastasis
    Han Sun, Liqun Luo, Bachchu Lal, Xinrong Ma, Lieping Chen, Christine L. Hann, Amy M. Fulton, Daniel J. Leahy, John Laterra, Min Li · 2016 · Nature Communications
  45. A Functional Variomics Tool for Discovering Drug-Resistance Genes and Drug Targets
    Zhiwei Huang, Kaifu Chen, Jianhuai Zhang, Yongxiang Li, Hui Wang, Dandan Cui, Jiangwu Tang, Yong Liu, Xiaomin Shi, Wěi Li et al. · 2013 · Cell Reports
  46. Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development
    Tan, Xueqiang, Huang, Zuyi, Pei, Hairun, Jia, Zongchao, Zheng, Jimin · 2024 · iScience
  47. Orphan Drugs and Their Impact on Pharmaceutical Development
    Misty M. Attwood, Mathias Rask‐Andersen, Helgi B. Schiöth · 2018 · Trends in Pharmacological Sciences
  48. Microbial Biotransformation to Obtain New Antifungals
    Luiz Fernando Bianchini, Maria Fernanda Cordeiro Arruda, Sérgio Vieira, Patrícia Maria Stuelp Campelo, Ana Maria Trindade Grégio, Edvaldo Antônio Ribeiro Rosa · 2015 · Frontiers in Microbiology
  49. Emerging drug development technologies targeting ubiquitination for cancer therapeutics
    Gianluca Veggiani, María Carla Rosales Gerpe, Sachdev S. Sidhu, Wei Zhang · 2019 · Pharmacology & Therapeutics
  50. Functionally biased signalling properties of 7TM receptors – opportunities for drug development for the ghrelin receptor
    Børge Sivertsen, Nicholas D. Holliday, Andreas Nygaard Madsen, Birgitte Holst · 2013 · British Journal of Pharmacology
  51. Therapeutic design of peptide modulators of protein-protein interactions in membranes
    Tracy A. Stone, Charles M. Deber · 2016 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  52. Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors
    Muhammad Zahid Khan, Ling He · 2017 · Psychopharmacology
  53. Gαi/o-coupled receptor-mediated sensitization of adenylyl cyclase: 40 years later
    Tarsis F. Brust, Jason Michael Conley, Val J. Watts · 2015 · European Journal of Pharmacology
  54. Histone deacetylases and their inhibitors in inflammatory diseases
    Sen-Yu Zhang, Liying Zhang, Ri Wen, Ni Yang, Tie‐Ning Zhang · 2024 · Biomedicine & Pharmacotherapy
  55. Lipid Nanodiscs for High-Resolution NMR Studies of Membrane Proteins
    Umut Günsel, Franz Hagn · 2021 · Chemical Reviews
  56. Can Specific Protein-Lipid Interactions Stabilize an Active State of the Beta 2 Adrenergic Receptor?
    Chris Neale, Henry David Herce, Régis Pomès, Angel E. Garcı́a · 2015 · Biophysical Journal
  57. Lost in translation: How to upgrade fear memory research
    Flores, África, Fullana, Miquel À., Soriano-Mas, Carles, Andero, Raül · 2018 · Molecular Psychiatry
  58. Lipid modulation of early G protein-coupled receptor signalling events
    Patricia M. Dijkman, Anthony Gordon Watts · 2015 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  59. Optical functionalization of human Class A orphan G-protein-coupled receptors
    Maurizio Morri, Inmaculada Sánchez-Romero, Alexandra‐Madelaine Tichy, Stephanie Kainrath, Elliot J. Gerrard, Priscila P. Hirschfeld, Jan Schwarz, Harald Janovjak · 2018 · Nature Communications
  60. The current status of anti-GPCR drugs against different cancers
    Sana Usman, Maria Khawer, Shazia Rafique, Zara Naz, Komal Saleem · 2020 · Journal of Pharmaceutical Analysis
  61. Deep learning large-scale drug discovery and repurposing
    Min Yu, Weiming Li, Yunru Yu, Yu Zhao, Lizhi Xiao, Volker Martin Lauschke, Yi-Yu Cheng, Xingcai Zhang, Yì Wáng · 2024 · Nature Computational Science
  62. G protein signaling in the parasite Entamoeba histolytica
    Dustin E. Bosch, David Peter Siderovski · 2013 · Experimental & Molecular Medicine
  63. Structure based virtual screening to discover putative drug candidates: Necessary considerations and successful case studies
    Mohd Danishuddin, Asad Ullah Khan · 2014 · Methods
  64. Natural products as kinase inhibitors
    Jing Liu, Yi Hu, David L. Waller, Junfeng Wang, Qingsong Liu · 2012 · Natural Product Reports
  65. Ube2V2 Is a Rosetta Stone Bridging Redox and Ubiquitin Codes, Coordinating DNA Damage Responses
    Yi Zhao, Marcus J. C. Long, Yiran Wang, Sheng Zhang, Yimon Aye · 2018 · ACS Central Science
  66. A Cell-Permeable Inhibitor to Trap Gαq Proteins in the Empty Pocket Conformation
    Anna-Lena Schmitz, Ramona Schrage, Evelyn Gaffal, Thomas H. Charpentier, Johannes M. Wiest, Georg Hiltensperger, Julia Morschel, Stephanie Hennen, Daniela Häußler, Velten Horn et al. · 2014 · Chemistry & Biology
  67. Regulation of G Protein-Coupled Receptors by Allosteric Ligands
    J. Robert Lane, Alaa Abdul‐Ridha, Meritxell Canals · 2013 · ACS Chemical Neuroscience
  68. Modern traditional Chinese medicine: Identifying, defining and usage of TCM components
    David J. Newman · 2019 · Advances in pharmacology
  69. Exploring the potential of 3D Zernike descriptors and SVM for protein–protein interface prediction
    Sebastian Daberdaku, Carlo Ferrari · 2018 · BMC Bioinformatics
  70. Advances in the study of GPCRs by 19F NMR
    Louis-Philippe Picard, Robert Scott Prosser · 2021 · Current Opinion in Structural Biology
  71. Strategies for Selecting Membrane Protein-Specific Antibodies using Phage Display with Cell-Based Panning
    Mohamed A. Alfaleh, Martina L. Jones, Christopher B. Howard, Stephen M. Mahler · 2017 · Antibodies
  72. Membrane cholesterol depletion reduces downstream signaling activity of the adenosine A2A receptor
    Claire E. McGraw, Lewen Yang, Ilya Levental, Edward R. Lyman, Anne Skaja Robinson · 2019 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  73. Challenges and achievements in the therapeutic modulation of aquaporin functionality
    Eric Beitz, André Golldack, Monja Rothert, Julia von Bülow · 2015 · Pharmacology & Therapeutics
  74. The GPCR repertoire in the demosponge Amphimedon queenslandica: insights into the GPCR system at the early divergence of animals
    Arunkumar Krishnan, Rohit Dnyansagar, Markus Sällman Almén, Michael J. Williams, Robert Fredriksson, Narayanan Manoj, Helgi Birgir Schiöth · 2014 · BMC Evolutionary Biology
  75. Biased Ligand Modulation of Seven Transmembrane Receptors (7TMRs): Functional Implications for Drug Discovery
    Craig C. Correll, Brian A. McKittrick · 2014 · Journal of Medicinal Chemistry
  76. Luteolin acts as a radiosensitizer in non-small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade
    Hyun-Ji Cho, Kwang-Chul Ahn, Jae Yeon Choi, Sang‐Gu Hwang, Wun‐Jae Kim, Hong‐Duck Um, Jong Kuk Park · 2015 · International Journal of Oncology
  77. What model organisms and interactomics can reveal about the genetics of human obesity
    Michael J. Williams, Markus Sällman Almén, Robert Fredriksson, Helgi Birgir Schiöth · 2012 · Cellular and Molecular Life Sciences
  78. Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics
    Tianyuan Zhou, Youngsoo Kim, A. Robert MacLeod · 2015 · Methods in molecular biology
  79. COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS
    Zheying Zhang, Cheng Fang, Yong‐Xia Wang, Jinghang Zhang, Jian Yu, Yongxi Zhang, Xianwei Wang, Jiateng Zhong · 2018 · International Journal of Oncology
  80. Structural insights into functional lipid–protein interactions in secondary transporters
    Caroline Koshy, Christine Maria Ziegler · 2014 · Biochimica et Biophysica Acta (BBA) - General Subjects
  81. Dopamine D1 receptor-mediated activation of the ERK signaling pathway is involved in the osteogenic differentiation of bone mesenchymal stem cells
    Chenxi Wang, Xi‐Yuan Ge, Mingyue Wang, Ting Ma, Yu Zhang, Ye Lin · 2020 · Stem Cell Research & Therapy
  82. Aptamers for Viral Detection and Inhibition
    Banani Chakraborty, Sreyashi Das, Arushi Gupta, Yanyu Xiong, Vyshnavi T-V, Megan E. Kizer, Jinwei Duan, Arun Richard Chandrasekaran, Xing Wang · 2022 · ACS Infectious Diseases
  83. Nuclear deterrents: Intrinsic regulators of IL-1β-induced effects on hippocampal neurogenesis
    Ciarán S. Ó’Léime, John F. Cryan, Yvonne M. Nolan · 2017 · Brain Behavior and Immunity
  84. Universality of the Sodium Ion Binding Mechanism in Class A G‐Protein‐Coupled Receptors
    Balaji Selvam, Zahra Shamsi, Diwakar Shukla · 2018 · Angewandte Chemie International Edition
  85. Solute carrier proteins and c-Myc: a strong connection in cancer progression
    Suman Panda, Nilanjan Banerjee, Subhrangsu Chatterjee · 2020 · Drug Discovery Today
  86. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma
    Wei Zhou, Guogui Sun, Zhen Zhang, Libo Zhao, Li Xu, Hongyu Yuan, Shumu Li, Zaizai Dong, Yongmei Song, Xiaohong Fang · 2019 · Journal of the American Chemical Society
  87. Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function
    Milad Rouhimoghadam, Anh S. Lu, Aliasger K. Salem, Edward J. Filardo · 2020 · Frontiers in Endocrinology
  88. Challenges in the Development of Functional Assays of Membrane Proteins
    Louis Tiefenauer, Sophie F. Demarche · 2012 · Materials
  89. The evolution of regulators of G protein signalling proteins as drug targets – 20 years in the making: IUPHAR Review 21
    Benita Sjögren · 2017 · British Journal of Pharmacology
  90. Comprehensive intra-individual genomic and transcriptional heterogeneity: Evidence-based Colorectal Cancer Precision Medicine
    Ioannis D Kyrochristos, Dimitrios H Roukos · 2019 · Cancer Treatment Reviews
  91. Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity
    Jing Cui, Yi Ding, Shu Chen, Xiaoqiang Zhu, Yichen Wu, Mingliang Zhang, Yaxin Zhao, Tong-Ruei R. Li, Ling V. Sun, Shimin Zhao et al. · 2016 · Journal of Clinical Investigation
  92. GPRC5A: An Emerging Biomarker in Human Cancer
    Xiaoxia Jiang, Xin Xu, Mengjie Wu, Zhonghai Guan, Xingyun Su, Shitu Chen, Haiyong Wang, Lisong Teng · 2018 · BioMed Research International
  93. Light-activated chimeric GPCRs: limitations and opportunities
    Alexandra‐Madelaine Tichy, Elliot J. Gerrard, Patrick Michael Sexton, Harald Janovjak · 2019 · Current Opinion in Structural Biology
  94. Systematic illumination of druggable genes in cancer genomes
    Junjie Jiang, Jiao Yuan, Zhongyi Hu, Youyou Zhang, Tianli Zhang, Mu Xu, Meixiao Long, Yi Fan, Janos Laszlo Tanyi, Kathleen T. Montone et al. · 2022 · Cell Reports
  95. Dopamine Receptor Antagonists as New Mode-of-Action Insecticide Leads for Control of Aedes and Culex Mosquito Vectors
    Andrew B. Nuss, Karin F.K. Ejendal, Trevor B. Doyle, Jason M. Meyer, Emma G. Lang, Val J. Watts, Catherine A. Hill · 2015 · PLoS neglected tropical diseases
  96. The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW
    Anne Cathrine Nøhr, Mohamed A. Shehata, Alexander S. Hauser, Vignir Ísberg, Jacek Mokrosiński, Kirsten Bayer Andersen, I. Sadaf Farooqi, Daniel Sejer Pedersen, David E.I. Gloriam, Hans Bräuner‐Osborne · 2016 · Neurochemistry International
  97. Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets.
    Seonghyeon Moon, Byung‐Hoon Lee · 2018 · Europe PMC (PubMed Central)
  98. Unexpected Complex Formation between Coralyne and Cyclic Diadenosine Monophosphate Providing a Simple Fluorescent Turn-on Assay to Detect This Bacterial Second Messenger
    Jie Zhou, David A. Sayre, Yue Zheng, Henryk Szmacinski, Herman O. Sintim · 2014 · Analytical Chemistry
  99. Target Essentiality and Centrality Characterize Drug Side Effects
    Xiujuan Wang, Bram Thijssen, Haiyuan Yu · 2013 · PLoS Computational Biology
  100. A Screening Pattern Recognition Method Finds New and Divergent Targets for Drugs and Natural Products
    Anne Mai Wassermann, Eugen Lounkine, László Urbán, Steven Whitebread, Shanni Chen, Kevin Hughes, Hongqiu Guo, Elena Kutlina, Alexander Fekete, Martin Klumpp et al. · 2014 · ACS Chemical Biology